Yap L, Wang J, Moreno Moral A, Chong L, Sun Y, Harmston N, et al. In Vivo Generation of Post-infarct Human Cardiac Muscle by Laminin-Promoted Cardiovascular Progenitors. Cell Rep. 2019;26:3231-3245.e9 pubmed publisher

Cheng A, Bouchard Cannon P, Hegazi S, Lowden C, Fung S, Chiang C, et al. SOX2-Dependent Transcription in Clock Neurons Promotes the Robustness of the Central Circadian Pacemaker. Cell Rep. 2019;26:3191-3202.e8 pubmed publisher

Flossmann T, Kaas T, Rahmati V, Kiebel S, Witte O, Holthoff K, et al. Somatostatin Interneurons Promote Neuronal Synchrony in the Neonatal Hippocampus. Cell Rep. 2019;26:3173-3182.e5 pubmed publisher

Harris D, Park J, Lee K, Xu C, Stella N, Hague C. Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells. J Pharmacol Exp Ther. 2017;361:219-228 pubmed publisher

Jiao K, Zeng G, Niu L, Yang H, Ren G, Xu X, et al. Activation of ?2A-adrenergic signal transduction in chondrocytes promotes degenerative remodelling of temporomandibular joint. Sci Rep. 2016;6:30085 pubmed publisher

Wang X, Hu W, Zhang T, Mao Y, Liu N, Wang S. Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity. Antiviral Res. 2015;120:140-6 pubmed publisher

Keten T, Aslan Y, Balci M, Tuncel A, Bilgin O, Dilmen C, et al. Determination of the efficiency of 8 mg doxazosin XL treatment in patients with an inadequate response to 4 mg doxazosin XL treatment for benign prostatic hyperplasia. Urology. 2015;85:189-94 pubmed publisher

Tomilov A, Golubtsova E. [Combined treatment of patients with lower urinary tract symptoms and erectile dysfunction]. Urologiia. 2013;:64-6, 68-9 pubmed

Chen Y, Palczewska G, Mustafi D, Golczak M, Dong Z, Sawada O, et al. Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration. J Clin Invest. 2013;123:5119-34 pubmed publisher

Conzo G, Musella M, Corcione F, Depalma M, Stanzione F, Della Pietra C, et al. Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma: a retrospective study of 48 cases. Am Surg. 2013;79:1196-202 pubmed

Pavlov V, Komiakov B, Grigor ev M, Sivkov A, Bliumberg B, Kazikhinoruv A, et al. [Results of open multicenter study of the safety of doxazosin in combination with indigal in men with stages I-II prostatic adenoma]. Urologiia. 2013;:42-4, 46 pubmed

Erturhan S, Bayrak O, Sarica K. Reply by the authors. Urology. 2013;81:1381-2 pubmed publisher

Stojkov N, Janjic M, Kostic T, Andric S. Orally applied doxazosin disturbed testosterone homeostasis and changed the transcriptional profile of steroidogenic machinery, cAMP/cGMP signalling and adrenergic receptors in Leydig cells of adult rats. Andrology. 2013;1:332-47 pubmed publisher

Fwu C, Eggers P, Kaplan S, Kirkali Z, Lee J, Kusek J. Long-term effects of doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia. J Urol. 2013;190:187-93 pubmed publisher

Erturhan S, Bayrak O, Sarica K, Seckiner I, Baturu M, Sen H. Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology. 2013;81:640-3 pubmed publisher

Yuan J, Liu Y, Yang Z, Qin X, Yang K, Mao C. The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews. Curr Med Res Opin. 2013;29:279-87 pubmed publisher

Conzo G, Musella M, Corcione F, De Palma M, Ferraro F, Palazzo A, et al. Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series. Int J Surg. 2013;11:152-6 pubmed publisher

Zhao D, Duan L, Wang F, Wang M, Lu H, Wu Z, et al. Chiral recognition of doxazosin enantiomers in 3 targets for therapy as well as adverse drug reactions in animal experiments. Can J Physiol Pharmacol. 2012;90:1623-33 pubmed publisher

Tung D, Ciallella J, Cheung P, Saha S. Novel anti-inflammatory effects of doxazosin in rodent models of inflammation. Pharmacology. 2013;91:29-34 pubmed publisher

Bahia L, Araujo D, Pepe C, Trindade M, Camargo C, Javaroni V. Cost-effectiveness analysis of medical treatment of benign prostatic hyperplasia in the Brazilian public health system. Int Braz J Urol. 2012;38:595-605 pubmed

Delella F, Lacorte L, Almeida F, Pai M, Felisbino S. Fibrosis-related gene expression in the prostate is modulated by doxazosin treatment. Life Sci. 2012;91:1281-7 pubmed publisher

Kudriavtsev I, Kirpatovskii V, Mudraia I, Khromov R, Kudriavtseva L. [Morphologic and functional heterogeneous changes of the urinary bladder different parts at rats with infravesical obstruction of the urinary tracts]. Arkh Patol. 2012;74:49-51 pubmed

Petty A, Myshkin E, Qin H, Guo H, Miao H, Tochtrop G, et al. A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo. PLoS ONE. 2012;7:e42120 pubmed publisher

Gedevanishvili M, Mushkiashvili N, Gogitidze N. Cholinergic stimulation of adrenal medulla is essential for the granulicytopoietic response to lithium. Georgian Med News. 2012;:43-6 pubmed

Jehle J, Staudacher I, Wiedmann F, Schweizer P, Becker R, Katus H, et al. Regulation of apoptosis in HL-1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid. Br J Pharmacol. 2012;167:1563-72 pubmed publisher

Lee J, Chae M, Park J, Jeon J, Lee S. The effects of the combined use of a PDE5 inhibitor and medications for hypertension, lower urinary tract symptoms and dyslipidemia on corporal tissue tone. Int J Impot Res. 2012;24:221-7 pubmed publisher

Hysek C, Liechti M. Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex. Psychopharmacology (Berl). 2012;224:363-76 pubmed publisher

Osman N, Chapple C. Lower urinary tract symptoms revisited. Int J Clin Pract. 2012;66:527-9 pubmed publisher

Gkaliagkousi E, Gavriilaki E, Nikolaidou B. Clarifying the role of preoperative α-blockade in pheochromocytoma?. J Hypertens. 2012;30:1045; author reply 1046 pubmed publisher

Hamada N, Nishi Y, Tajiri Y, Setoyama K, Kamimura R, Miyahara K, et al. Disrupted regulation of ghrelin production under antihypertensive treatment in spontaneously hypertensive rats. Circ J. 2012;76:1423-9 pubmed

Groeben H. [Preoperative ?-receptor block in patients with pheochromocytoma? Against]. Chirurg. 2012;83:551-4 pubmed publisher

Lynch A, Eckfeldt J, Davis B, Ford C, Boerwinkle E, Leiendecker Foster C, et al. Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study. Pharmacogenet Genomics. 2012;22:355-66 pubmed publisher

Goldfischer E, Kowalczyk J, Clark W, Brady E, Shane M, Dgetluck N, et al. Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial. Urology. 2012;79:875-82 pubmed publisher

Newton T, De La Garza R, Brown G, Kosten T, Mahoney J, Haile C. Noradrenergic α₁ receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. PLoS ONE. 2012;7:e30854 pubmed publisher

Zhang Y, Byun Y, Ren Y, Liu J, Laterra J, Pomper M. Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay. Cancer Res. 2009;69:5867-75 pubmed publisher